Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Drishti Panjwani, Shruti Patel, Deepak Mishra, Viral Patel, MangeRam Yadav, Abhay Dharamsi & Asha Patel. (2023) Avidin-Biotin functionalized self-assembled protein nanoparticles as EGFR targeted therapeutics for the treatment of lung cancer: characterization and cell viability. Journal of Dispersion Science and Technology 44:13, pages 2483-2496.
Read now
Read now
Nariman Shahid, Alia Erum, Muhammad Zaman, Ume Ruqia Tulain, Qurat-ul-ain Shoaib, Abdul Majeed, Muhammad F Rasool, Imran Imran, Sultan Alshehri, Behnam Noorani & Faleh Alqahtani. (2021) pH-Responsive Nanocomposite Based Hydrogels for the Controlled Delivery of Ticagrelor; In Vitro and In Vivo Approaches. International Journal of Nanomedicine 16, pages 6345-6366.
Read now
Read now
Benjian Gao, Jia Luo, Ying Liu, Song Su, Shaozhi Fu, Xiaoli Yang & Bo Li. (2021) Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma. International Journal of Nanomedicine 16, pages 4073-4085.
Read now
Read now
Yonglong Jin, Yi Wang, Xiguang Liu, Jing Zhou, Xintong Wang, Hui Feng & Hong Liu. (2020) Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers. Drug Design, Development and Therapy 14, pages 5205-5215.
Read now
Read now
Ruifeng Wu, Zhiqiang Zhang, Baohua Wang, Ge Chen, Yaozhong Zhang, Haowen Deng, Zilong Tang, Junjie Mao & Lei Wang. (2020) Combination Chemotherapy of Lung Cancer – Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid–Polymer Hybrid Nanoparticles. Drug Design, Development and Therapy 14, pages 2249-2261.
Read now
Read now
Nazafarin Satari, Somayeh Taymouri, Jaleh Varshosaz, Mahboubeh Rostami & Mina Mirian. (2020) Preparation and evaluation of inhalable dry powder containing glucosamine-conjugated gefitinib SLNs for lung cancer therapy. Drug Development and Industrial Pharmacy 46:8, pages 1265-1277.
Read now
Read now
Heba S. Elsewedy, Bandar E. Al Dhubiab, Mahmoud A. Mahdy & Hanan M. Elnahas. (2020) Development, optimization, and evaluation of PEGylated brucine-loaded PLGA nanoparticles. Drug Delivery 27:1, pages 1134-1146.
Read now
Read now
Min Wu, Jing Liu, ChuanFei Hu, Dong Li, Juan Yang, ZhouXue Wu, LingLin Yang, Yue Chen, ShaoZhi Fu & JingBo Wu. (2018) Olaparib nanoparticles potentiated radiosensitization effects on lung cancer. International Journal of Nanomedicine 13, pages 8461-8472.
Read now
Read now
Jia Liu, Hao Cheng, Le Han, Zhun Qiang, Xinwei Zhang, Wei Gao, Kun Zhao & Yangrong Song. (2018) Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid–polymer hybrid nanoparticles. Drug Design, Development and Therapy 12, pages 3199-3209.
Read now
Read now
Articles from other publishers (35)
S. Chemmalar, A. R. Intan Shameha, Che Azurahanim Che Abdullah, Nor Asma Ab Razak, Loqman Mohamad Yusof, Mokrish Ajat, Kim Wei Chan & Md Zuki Abu Bakar Zakaria. (2023) Busting the Breast Cancer with AstraZeneca’s Gefitinib. Advances in Pharmacological and Pharmaceutical Sciences 2023, pages 1-26.
Crossref
Crossref
Deepak Nagdiya, Manish Kumar, Sanchit Arora, Tania Bajaj, Sima Kujur, Prinsy Rana, Arun Kumar, Arti Singh & Charan Singh. (2023) Drug delivery systems of gefitinib for improved cancer therapy: A review. OpenNano 14, pages 100183.
Crossref
Crossref
Gitika Rani, Seema Rohilla, Ankur Rohilla, Vanish Kumar & Ishab Kumar. (2023) Antirheumatoid arthritis and cellular uptake study of cefuroxime axetil-loaded boswellic acids nanoparticles on RAW 264.7 cells. Future Journal of Pharmaceutical Sciences 9:1.
Crossref
Crossref
Minakshi Gupta Marwaha, Rajendra Awasthi, Rakesh Kumar Marwaha, Parteek Prasher, Monica Gulati, Sachin Kumar Singh, Krishnan Anand, Gaurav Gupta, Dinesh Kumar Chellappan, Kamal Dua & Harish Dureja. (2023) Emerging Applications of Polymeric Nanoparticles in Tumor Targeting. Current Nanoscience 19:5, pages 677-696.
Crossref
Crossref
Bahareh Farasati Far, Ali Attaripour Isfahani, Elnaz Nasiriyan, Ali Pourmolaei, Golnaz Mahmoudvand, Arian Karimi Rouzbahani, Mohammed Namiq Amin & Mohammad Reza Naimi-Jamal. (2023) An Updated Review on Advances in Hydrogel-Based Nanoparticles for Liver Cancer Treatment. Livers 3:2, pages 161-189.
Crossref
Crossref
Gamaleldin I. Harisa, Abdelrahman Y. Sherif, Fars K. Alanazi, Essam A. Ali, Gamal A. Omran, Fahd A. Nasr, Sabry M. Attia & Ali S. Alqahtani. (2023) TPGS decorated NLC shift gefitinib from portal absorption into lymphatic delivery: Intracellular trafficking, biodistribution and bioavailability studies. Colloids and Surfaces B: Biointerfaces 223, pages 113148.
Crossref
Crossref
Gabriela Bordeianu, Nina Filip, Andrei Cernomaz, Bogdan Veliceasa, Loredana Liliana Hurjui, Alin Constantin Pinzariu, Mihaela Pertea, Andreea Clim, Mihai Vasile Marinca & Ionela Lacramioara Serban. (2023) The Usefulness of Nanotechnology in Improving the Prognosis of Lung Cancer. Biomedicines 11:3, pages 705.
Crossref
Crossref
Abdelrahman Y. Sherif, Gamaleldin I. Harisa, Ahmad A. Shahba, Fars K. Alanazi & Wajhul Qamar. (2023) Optimization of Gefitinib-Loaded Nanostructured Lipid Carrier as a Biomedical Tool in the Treatment of Metastatic Lung Cancer. Molecules 28:1, pages 448.
Crossref
Crossref
Ali Jadidi, Mohammad Ali Shokrgozar, Soroush Sardari & Amir Mohammad Maadani. (2022) Gefitinib-loaded polydopamine-coated hollow mesoporous silica nanoparticle for gastric cancer application. International Journal of Pharmaceutics 629, pages 122342.
Crossref
Crossref
Shiming Hao, Qingfei Meng, Huihui Sun, Yunkuo Li, Yao Li, Liting Gu, Bin Liu, Yanghe Zhang, Honglan Zhou, Zhixiang Xu & Yishu Wang. (2022) The role of transketolase in human cancer progression and therapy. Biomedicine & Pharmacotherapy 154, pages 113607.
Crossref
Crossref
Seema Rohilla, Rajendra Awasthi, Meenu Mehta, Dinesh Kumar Chellappan, Gaurav Gupta, Monica Gulati, Sachin Kumar Singh, Krishnan Anand, Brian G. Oliver, Kamal Dua & Harish Dureja. (2022) Preparation and Evaluation of Gefitinib Containing Nanoliposomal Formulation for Lung Cancer Therapy. BioNanoScience 12:1, pages 241-255.
Crossref
Crossref
Disha Mittal, Karishma Niveria & Anita Kamra Verma. 2022. Protein Kinase Inhibitors. Protein Kinase Inhibitors
747
779
.
Qian Wen, Yan Zhang, Tobias Achu Muluh, Kang Xiong, BiQiong Wang, Yun Lu, ZhouXue Wu, YanLin Liu, Huan Shi, SuSu Xiao & ShaoZhi Fu. (2021) Erythrocyte membrane-camouflaged gefitinib/albumin nanoparticles for tumor imaging and targeted therapy against lung cancer. International Journal of Biological Macromolecules 193, pages 228-237.
Crossref
Crossref
Abdullah S. Alshetaili. (2021) Gefitinib loaded PLGA and chitosan coated PLGA nanoparticles with magnified cytotoxicity against A549 lung cancer cell lines. Saudi Journal of Biological Sciences 28:9, pages 5065-5073.
Crossref
Crossref
Ana Rita Garizo, Flávia Castro, Cláudia Martins, Andreia Almeida, Tiago P. Dias, Fábio Fernardes, Cristina C. Barrias, Nuno Bernardes, Arsénio M. Fialho & Bruno Sarmento. (2021) p28-functionalized PLGA nanoparticles loaded with gefitinib reduce tumor burden and metastases formation on lung cancer. Journal of Controlled Release 337, pages 329-342.
Crossref
Crossref
Xinglong Fan, Tian Wang, Zhongyi Ji, Qingpeng Li, Hongyu Shen & Jun Wang. (2021) Synergistic combination therapy of lung cancer using lipid-layered cisplatin and oridonin co-encapsulated nanoparticles. Biomedicine & Pharmacotherapy 141, pages 111830.
Crossref
Crossref
Sultan Alshehri, Abdullah Alanazi, Ehab M. Elzayat, Mohammad A. Altamimi, Syed S. Imam, Afzal Hussain, Faleh Alqahtani & Faiyaz Shakeel. (2021) Formulation, In Vitro and In Vivo Evaluation of Gefitinib Solid Dispersions Prepared Using Different Techniques. Processes 9:7, pages 1210.
Crossref
Crossref
Akshat Shah, Asha Patel & Abhay Dharamsi. (2021) Optimization of Solid Lipid Nanoparticles and Nanostructured Lipidic Carriers as Promising Delivery for Gefitinib: Characterization and Invitro Evaluation. Current Drug Therapy 16:2, pages 170-183.
Crossref
Crossref
Vaidevi Sethuraman, Kumar Janakiraman, Venkateshwaran Krishnaswami, Subramanian Natesan & Ruckmani Kandasamy. (2021) In vivo synergistic anti-tumor effect of lumefantrine combined with pH responsive behavior of nano calcium phosphate based lipid nanoparticles on lung cancer. European Journal of Pharmaceutical Sciences 158, pages 105657.
Crossref
Crossref
Sujit Nayek, N.M. Raghavendra & B. Sajeev Kumar. (2021) Development of novel S PC-3 gefitinib lipid nanoparticles for effective drug delivery in breast cancer. Tissue distribution studies and cell cytotoxicity analysis. Journal of Drug Delivery Science and Technology 61, pages 102073.
Crossref
Crossref
Juan Yang, ZhouXue Wu, Yao Chen, ChuanFei Hu, Dong Li, Yue Chen, Saber Imani, QingLian Wen, ShaoZhi Fu & JingBo Wu. (2020) Pre-treatment with Bifidobacterium infantis and its specific antibodies enhance targeted radiosensitization in a murine model for lung cancer. Journal of Cancer Research and Clinical Oncology 147:2, pages 411-422.
Crossref
Crossref
Lin Cao, Weipeng Hong, Peiheng Cai, Chuncao Xu, Xupeng Bai, Zhongxiang Zhao, Min Huang & Jing Jin. (2021) Cryptotanshinone strengthens the effect of gefitinib against non-small cell lung cancer through inhibiting transketolase. European Journal of Pharmacology 890, pages 173647.
Crossref
Crossref
Heba S. Elsewedy, Bandar E. Aldhubiab, Mahmoud A. Mahdy & Hanan M. Elnahas. (2021) Brucine PEGylated nanoemulsion: In vitro and in vivo evaluation. Colloids and Surfaces A: Physicochemical and Engineering Aspects 608, pages 125618.
Crossref
Crossref
Sathishbabu Paranthaman, Meghana Goravinahalli Shivananjegowda, Manohar Mahadev, Afrasim Moin, Shivakumar Hagalavadi Nanjappa, Nandakumar Dalavaikodihalli Nanjaiyah, Saravana Babu Chidambaram & Devegowda Vishakante Gowda. (2020) Nanodelivery Systems Targeting Epidermal Growth Factor Receptors for Glioma Management. Pharmaceutics 12:12, pages 1198.
Crossref
Crossref
Xiaohan Zhou, Xinlong He, Kun Shi, Liping Yuan, Yun Yang, Qingya Liu, Yang Ming, Cheng Yi & Zhiyong Qian. (2020) Injectable Thermosensitive Hydrogel Containing Erlotinib‐Loaded Hollow Mesoporous Silica Nanoparticles as a Localized Drug Delivery System for NSCLC Therapy. Advanced Science 7:23.
Crossref
Crossref
Neeta Solanki, Meenu Mehta, Dinesh Kumar Chellappan, Gaurav Gupta, Nicole G Hansbro, Murtaza M Tambuwala, Alaa AA Aljabali, Keshav Raj Paudel, Gang Liu, Saurabh Satija, Philip M Hansbro, Kamal Dua & Harish Dureja. (2020) Antiproliferative effects of boswellic acid-loaded chitosan nanoparticles on human lung cancer cell line A549. Future Medicinal Chemistry 12:22, pages 2019-2034.
Crossref
Crossref
Brian Madajewski, Feng Chen, Barney Yoo, Melik Z. Turker, Kai Ma, Li Zhang, Pei-Ming Chen, Rupa Juthani, Virginia Aragon-Sanabria, Mithat Gonen, Charles M. Rudin, Ulrich Wiesner, Michelle S. Bradbury & Cameron Brennan. (2020) Molecular Engineering of Ultrasmall Silica Nanoparticle–Drug Conjugates as Lung Cancer Therapeutics. Clinical Cancer Research 26:20, pages 5424-5437.
Crossref
Crossref
Sarah Visentin, Mirela Sedić, Sandra Kraljević Pavelić & Krešimir Pavelić. (2020) Targeting Tumour Metastasis: The Emerging Role of Nanotechnology. Current Medicinal Chemistry 27:8, pages 1367-1381.
Crossref
Crossref
Abdullah Alanazi, Sultan Alshehri, Mohammad Altamimi & Faiyaz Shakeel. (2020) Solubility determination and three dimensional Hansen solubility parameters of gefitinib in different organic solvents: Experimental and computational approaches. Journal of Molecular Liquids 299, pages 112211.
Crossref
Crossref
Yanlong Yin, Xiao Yuan, Huile Gao & Qian Yang. (2020) Nanoformulations of small molecule protein tyrosine kinases inhibitors potentiate targeted cancer therapy. International Journal of Pharmaceutics 573, pages 118785.
Crossref
Crossref
Xiaohan Zhou, Kun Shi, Ying Hao, Chengli Yang, Ruoyu Zha, Cheng Yi & Zhiyong Qian. (2020) Advances in nanotechnology-based delivery systems for EGFR tyrosine kinases inhibitors in cancer therapy. Asian Journal of Pharmaceutical Sciences 15:1, pages 26-41.
Crossref
Crossref
Liying Wang, Xinru You, Qi Lou, Siyu He, Junfu Zhang, Chunlei Dai, Meng Zhao, Minyi Zhao, Hai Hu & Jun Wu. (2019) Cysteine-based redox-responsive nanoparticles for small-molecule agent delivery. Biomaterials Science 7:10, pages 4218-4229.
Crossref
Crossref
Fu Yugui, Hailan Wang, Dezhong Sun & Xiaoyan Zhang. (2019) Nasopharyngeal cancer combination chemoradiation therapy based on folic acid modified, gefitinib and yttrium 90 co-loaded, core-shell structured lipid-polymer hybrid nanoparticles. Biomedicine & Pharmacotherapy 114, pages 108820.
Crossref
Crossref
M. Gupta, R.K. Marwaha & H. Dureja. (2019) Formulation and Characterization of Gefitinib-loaded Polymeric Nanoparticles Using Box-Behnken Design. Current Nanomedicine 9:1, pages 46-60.
Crossref
Crossref
Poonam Parashar, Chandra Bhushan Tripathi, Malti Arya, Jovita Kanoujia, Mahendra Singh, Abhishek Yadav, Gaurav Kaithwas & Shubhini A Saraf. (2019) A synergistic approach for management of lung carcinoma through folic acid functionalized co-therapy of capsaicin and gefitinib nanoparticles: Enhanced apoptosis and metalloproteinase-9 down-regulation. Phytomedicine 53, pages 107-123.
Crossref
Crossref